<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02833116</url>
  </required_header>
  <id_info>
    <org_study_id>Beta-Dexa-Caudal</org_study_id>
    <nct_id>NCT02833116</nct_id>
  </id_info>
  <brief_title>Epidural Dexamethasone Versus Betamethasone for Treatment of Lumbosacral Radiculalgia</brief_title>
  <acronym>BetaDexaCaudal</acronym>
  <official_title>Efficacy and Safety of Dexamethasone Versus Betamethasone Epidural Caudal Administration for Treatment of Lumbosacral Radiculalgia: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Basque Health Service</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Basque Health Service</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the administration of epidural betamethasone versus dexamethasone for
      pain reduction, consumption of analgesic and quality of life. Half of the patient will
      receive dexametasone and the other half betametasone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain.</measure>
    <time_frame>3 months.</time_frame>
    <description>Pain according to numerical visual pain scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life.</measure>
    <time_frame>7 days, 1, 3 and 6 months.</time_frame>
    <description>Quality of life according to SF-36.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain.</measure>
    <time_frame>7 days, 1, 3 and 6 months.</time_frame>
    <description>Pain according to numerical visual pain scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events.</measure>
    <time_frame>7 days, 1, 3 and 6 months.</time_frame>
    <description>Adverse events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Group Betamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One ampule containing 12 mg of betamethasone in a syringe of 10 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One ampule containing 4 mg of dexamethasone in a syringe os 10 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betamethasone</intervention_name>
    <arm_group_label>Group Betamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <arm_group_label>Group Dexamethasone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral leg pain secondary to lateral stenosis, disc protrusion or herniated disc.

          -  Age between 18 and 80 years.

          -  Moderate to severe pain (NVS&gt;4).

          -  Right proficient oral and written language.

        Exclusion Criteria:

          -  Patients with high intracranial pressure.

          -  Patients with Multiple Sclerosis.

          -  Patients with Guillain-Barré syndrome radiculopathy of vascular origin.

          -  Patients with previous lumbar surgery.

          -  Patients pregnant or lactating.

          -  Patients with allergy or intolerance to any of the drugs used.

          -  Patients with severe cognitive impairment.

          -  Patients with intrathecal injectio radiculalgia.

          -  Patients with poorly controlled major psychiatric pathology.

          -  Patients with type I diabetes or poorly controlled type II diabetes (Hb1Ac&gt;8.5).

          -  Patients with glaucoma.

          -  Patients with caudal equine syndrome.

          -  Patients with pre-treatment with steroid injections/or local anesthetics.

          -  Patients with central canal stenosis.

          -  patients with chronic treatment with oral corticosteroids without stabilized pattern.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Barez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Basque Health Service: Araba University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Borja Mugabure</last_name>
    <role>Study Director</role>
    <affiliation>Basque Health Service: Donosti University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernando Torre</last_name>
    <role>Principal Investigator</role>
    <affiliation>Basque Health Service: Galdakao University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enrique Barez</last_name>
    <phone>+34945007246</phone>
    <email>ENRIQUEMANUEL.BAREZHERNANDEZ@osakidetza.eus</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amanda Lopez</last_name>
    <phone>+34945007413</phone>
    <email>AMANDA.LOPEZPICADO@osakidetza.eus</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Enrique Barez</name>
      <address>
        <city>Vitoria-Gasteiz</city>
        <state>Álava</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Barez</last_name>
      <phone>+34945007275</phone>
      <email>ENRIQUEMANUEL.BAREZHERNANDEZ@osakidetza.eus</email>
    </contact>
    <contact_backup>
      <last_name>Amanda Lopez</last_name>
      <phone>+34945007413</phone>
      <email>AMANDA.LOPEZPICADO@osakidetza.eus</email>
    </contact_backup>
    <investigator>
      <last_name>Borja Mugabure</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Torre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2016</study_first_submitted>
  <study_first_submitted_qc>July 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Basque Health Service</investigator_affiliation>
    <investigator_full_name>Enrique Manuel Barez Hernandez</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>radiculalgia</keyword>
  <keyword>chronic pain</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

